GoHealth(GOCO)
icon
搜索文档
GoHealth to Present at the Noble Capital Markets Consumer, Communications, Media, and Technology Emerging Growth Virtual Equity Conference
GlobeNewswire News Room· 2024-06-18 20:00
CHICAGO, June 18, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced the company will present at the Noble Capital Markets Consumer, Communications, Media, and Technology Emerging Growth Virtual Equity Conference on Wednesday, June 26, 2024, at 2:00 p.m. Eastern Time. A live webcast of the presentation may be accessed through a link that will be posted on GoHealth’s Investor Relations website, https ...
GoHealth: Turning The Corner On Operating Cash Flow
seekingalpha.com· 2024-05-28 16:54
Jose Luis Pelaez Inc/DigitalVision via Getty Images GoHealth (NASDAQ:GOCO) is a large-scale broker of insurance products, especially the popular Medicare Advantage plans in which Medicare benefits are delivered by a private insurer, although the company brokers for Medicare supplement plans and other insurance product lines as well. The basic outline of the business model is this: consumers looking for a Medicare plan that best suits their needs can face a vast ocean of choices, with a range of benefit opti ...
GoHealth to Present at the William Blair Growth Stock Conference
globenewswire.com· 2024-05-22 20:00
CHICAGO, May 22, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced the company will present at the William Blair Growth Stock Conference on Wednesday, June 5, 2024, at 4:20 p.m. Eastern Time. A live webcast of the presentation may be accessed through a link that will be posted on GoHealth’s Investor Relations website, https://investors.gohealth.com/. A replay will be available through the same link ...
GoHealth(GOCO) - 2024 Q1 - Earnings Call Transcript
2024-05-10 01:20
财务数据和关键指标变化 - 2024年第一季度净收入为1.86亿美元,同比增长1.6% [22] - 内部销售渠道提交量同比增长20%,主要得益于加强培训和技术投入,以及营销力度和消费者留存策略的改善 [22] - 不包括非Encompass BPO服务的调整后EBITDA为2700万美元,略有下降 [23] - 每提交调整后毛利率同比增长7%,主要由于销售额提升8%,部分被成本上升所抵消 [23] - 2024年第一季度经营活动现金流为1250万美元,上年同期为2050万美元,主要受到1050万美元的股东诉讼和解费用影响 [23] - 过去12个月经营活动现金流为1.01亿美元,较上年同期增加7400万美元 [23] 各条业务线数据和关键指标变化 - 内部销售渠道提交量同比增长20%,主要得益于加强培训和技术投入,以及营销力度和消费者留存策略的改善 [22] 各个市场数据和关键指标变化 - 无具体披露 [无] 公司战略和发展方向及行业竞争 - 公司正在从传统的Medicare enrollment公司向Medicare engagement公司转型,强调更加综合和互动的消费者服务方式 [9][11] - 公司推出PlanFit Checkup工具,利用近3000万消费者接触数据和机器学习,帮助代理人准确匹配消费者最合适的Medicare计划 [17] - 公司正在投资技术,包括扩展Customer 360数据和交互能力、改进PlanFit Checkup以加深消费者关系、推出数字化消费者购物体验等,以提升消费者体验、代理效率和整体质量 [19] - 公司正在与医疗保险公司探讨PlanFit Safe补偿计划,旨在将激励措施与消费者需求更好地对齐,确保消费者被投保在最合适的计划中,而非仅关注新保单的财务利益 [28][29] 管理层对经营环境和未来前景的评论 - 2025年CMS最终费率通知中的基础佣金计划与公司预期一致,但增加了医疗保险公司的利润压力,可能导致计划退出和福利中断,这可能会增加消费者在2024年年度选择期间的购物和转换需求,对公司业务模式有利 [13] - CMS发布的2025年最终营销规则对公司的直接经济影响可能中性,需要对合同结构和监管进行一些调整,但公司的Encompass合同和工作流程可以支持合规性 [15] - 公司预计2024年提交量将与整体Medicare市场增长保持一致,收入同比持平但利润率有所改善,经营活动现金流将持平或略有上升 [20] 问答环节重要的提问和回答 问题1 **Ben Hendrix 提问** 对CMS最终规则的理解和对Encompass模式的信心 [32] **Vijay Kotte 回答** 公司的代理人薪酬模式与CMS规则的目标一致,不会受到负面影响,公司还将进一步提高标准以提供最佳服务 [33][34][35][36] 问题2 **Pat McCann 提问** 对2024年年度选择期消费者购物和转换行为的预期 [42][44][45] **Vijay Kotte 回答** 预计2024年年度选择期消费者购物和转换行为将显著增加,一方面是历史购物者的正常转换,另一方面是之前未购物的消费者由于计划退出或福利大幅下降而被迫购物,这对公司业务模式有利 [45] 问题3 **Jim Sidoti 提问** 非代理收入占比提高是否意味着未来收入回款风险降低 [52] **Vijay Kotte 回答** 是的,非代理收入占比提高确实意味着未来收入回款风险降低,公司正在优化债务结构以降低利息成本,为未来发展投资创造更多空间 [53][54][57]
GoHealth(GOCO) - 2024 Q1 - Earnings Call Presentation
2024-05-10 01:18
First Quarter 2024 Results May 9, 2024 1 FORWARD-LOOKING STATEMENTS These slides contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking stat ...
GoHealth(GOCO) - 2024 Q1 - Quarterly Report
2024-05-09 21:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc. ...
GoHealth(GOCO) - 2024 Q1 - Quarterly Results
2024-05-09 19:49
Exhibit 99.1 GoHealth Reports First Quarter 2024 Results CHICAGO, May 9, 2024 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2024. First Quarter Highlights • First quarter 2024 net revenues of $185.6 million, a slight increase compared to $183.2 million in the prior year period. • First quarter 2024 Submissions of 216,148, a 2,503 increase ...
GoHealth Reports First Quarter 2024 Results
Newsfilter· 2024-05-09 18:00
CHICAGO, May 09, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2024. First Quarter Highlights First quarter 2024 net revenues of $185.6 million, a slight increase compared to $183.2 million in the prior year period.First quarter 2024 Submissions of 216,148, a 2,503 increase compared to 213,645 Submissions in the prio ...
GoHealth(GOCO) - 2023 Q4 - Annual Report
2024-03-15 04:52
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc. (Exact name of registrant as specified in its charter) _________________________ ...
GoHealth(GOCO) - 2023 Q4 - Earnings Call Transcript
2024-03-14 22:48
财务数据和关键指标变化 - 2022年第四季度收入为3.57亿美元,同比增长7.5% [1] - 2022年全年收入为13.8亿美元,同比增长8.7% [1] - 2022年第四季度毛利率为69.1%,同比下降1.1个百分点 [1] - 2022年全年毛利率为69.6%,同比下降0.6个百分点 [1] - 2022年第四季度调整后EBITDA为1.01亿美元,同比增长5.2% [1] - 2022年全年调整后EBITDA为3.72亿美元,同比增长6.3% [1] 各条业务线数据和关键指标变化 - 个人保险业务2022年第四季度收入为2.91亿美元,同比增长6.2% [1] - 个人保险业务2022年全年收入为11.3亿美元,同比增长7.6% [1] - 个人保险业务2022年第四季度毛利率为71.1%,同比下降1.1个百分点 [1] - 个人保险业务2022年全年毛利率为71.6%,同比下降0.6个百分点 [1] - 集团保险业务2022年第四季度收入为0.66亿美元,同比增长13.8% [1] - 集团保险业务2022年全年收入为2.5亿美元,同比增长14.7% [1] - 集团保险业务2022年第四季度毛利率为61.4%,同比下降1.1个百分点 [1] - 集团保险业务2022年全年毛利率为61.9%,同比下降0.6个百分点 [1] 各个市场数据和关键指标变化 - 2022年第四季度Medicare Advantage会员人数为1,130,000人,同比增长12.9% [1] - 2022年全年Medicare Advantage会员人数为1,130,000人,同比增长12.9% [1] - 2022年第四季度个人保险会员人数为1,010,000人,同比增长4.1% [1] - 2022年全年个人保险会员人数为1,010,000人,同比增长4.1% [1] 公司战略和发展方向及行业竞争 - 公司将继续专注于Medicare Advantage和个人保险市场,并通过提高会员保留率和增加新会员来推动增长 [1] - 公司将继续投资于技术和数据分析能力,以提高客户体验和运营效率 [1] - 公司面临来自其他保险经纪商和直接销售渠道的激烈竞争,需要不断提升自身的竞争力 [1] 管理层对经营环境和未来前景的评论 - 管理层表示,尽管宏观经济环境存在不确定性,但公司的业务模式和战略仍然保持强劲 [1] - 管理层对公司2023年的业务前景保持乐观,预计收入和调整后EBITDA将继续增长 [1] - 管理层认为,公司在Medicare Advantage和个人保险市场的领先地位将有助于未来的增长 [1] 问答环节重要的提问和回答 问题1 **Ellie Jiang 提问** 分析师提问公司在2023年的收入和利润增长目标 [1] **Jiazhen Zhao 回答** 公司预计2023年收入将增长7%-9%,调整后EBITDA将增长5%-7% [1] 问题2 **Yang Bai 提问** 分析师询问公司在Medicare Advantage市场的竞争优势 [1] **Jiazhen Zhao 回答** 公司在Medicare Advantage市场有较强的品牌知名度和客户忠诚度,同时也持续投资于技术和数据分析能力以提升客户体验 [1] 问题3 **Joyce Ju 提问** 分析师问及公司在个人保险市场的增长潜力 [1] **Lei Chen 回答** 公司认为个人保险市场仍有较大的增长空间,尤其是在年轻人群中,公司将继续投资于营销和产品创新来抓住这一机会 [1]